AL amyloid of the gastrointestinal tract involves the stomach in 8 % of cases [1] . Only 1 % of patients with gastric amyloi− dosis manifest symptoms such as bleed− ing [1, 2] , which has been attributed to light−chain deposition in blood vessels causing increased friability and eventual bowel infarction [2, 3] . Characteristic endoscopic findings include thickened folds, mucosal erosions, submucosal he− matomas, ulcerations, and mucosal fria− bility [2] . Histology demonstrates deposi− tion of amorphous hyaline material on H&E stain which is Congo−red−stain−posi− tive. Treatment of AL amyloid is aimed at the underlying plasma cell disorder in or− der to decrease light−chain production. High−dose melphalan followed by autolo− gous−SCT induces a complete hematolo− gic response in the majority of patients in about 3 months [4, 5] . This therapy may be associated with significant toxici− ty, especially in patients with underlying cardiac disease. There are very limited published data documenting reversal of symptomatic gastrointestinal amyloid with multiple myeloma therapy [4, 5] . We believe this is the first reported case of complete en− doscopic and histologic resolution of gas− trointestinal amyloid, particularly gastro− intestinal amyloid causing bleeding, fol− lowing autologous−SCT. In carefully se− lected patients with multiple myeloma, high−dose melphalan followed by autolo− gous−SCT may be effective for sympto− matic AL amyloid of the gastrointestinal tract.
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Complete resolution of gastric amyloidosis after autologous stem cell transplantation 
Video 1
Large ulcer in the cardia containing a bleeding pigmented lesion. Numerous additional le− sions are present throughout the stomach which, upon probing, are friable and necrotic.
Video 2
Complete resolution of gastric amyloid 10 months after autologous stem cell transplan− tation.
